Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Human Cancer Biology

Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

Takashi Nakaoku, Koji Tsuta, Hitoshi Ichikawa, Kouya Shiraishi, Hiromi Sakamoto, Masato Enari, Koh Furuta, Yoko Shimada, Hideaki Ogiwara, Shun-ichi Watanabe, Hiroshi Nokihara, Kazuki Yasuda, Masaki Hiramoto, Takao Nammo, Teruhide Ishigame, Aaron J. Schetter, Hirokazu Okayama, Curtis C. Harris, Young Hak Kim, Michiaki Mishima, Jun Yokota, Teruhiko Yoshida and Takashi Kohno
Takashi Nakaoku
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koji Tsuta
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hitoshi Ichikawa
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kouya Shiraishi
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiromi Sakamoto
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masato Enari
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koh Furuta
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoko Shimada
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideaki Ogiwara
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shun-ichi Watanabe
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Nokihara
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuki Yasuda
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masaki Hiramoto
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takao Nammo
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teruhide Ishigame
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron J. Schetter
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hirokazu Okayama
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Curtis C. Harris
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Young Hak Kim
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michiaki Mishima
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Yokota
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teruhiko Yoshida
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takashi Kohno
Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-14-0107 Published June 2014
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: April 2014 to February 2021

AbstractFull-text HTMLPDF
Total565152134108

Cited By

Article Information

Volume 20, Issue 12, pp. 3087-3093

DOI 
https://doi.org/10.1158/1078-0432.CCR-14-0107
PubMed 
24727320

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Received January 14, 2014
  • Revision received March 22, 2014
  • Accepted April 1, 2014
  • Published first April 11, 2014.

Article Versions

  • Previous version (April 11, 2014 - 07:32).
  • Previous version (May 22, 2014 - 08:21).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2014 American Association for Cancer Research.

Author Information

  1. Takashi Nakaoku1,8,
  2. Koji Tsuta4,
  3. Hitoshi Ichikawa2,
  4. Kouya Shiraishi1,
  5. Hiromi Sakamoto2,
  6. Masato Enari3,
  7. Koh Furuta4,
  8. Yoko Shimada1,
  9. Hideaki Ogiwara1,
  10. Shun-ichi Watanabe5,
  11. Hiroshi Nokihara6,
  12. Kazuki Yasuda7,
  13. Masaki Hiramoto7,
  14. Takao Nammo7,
  15. Teruhide Ishigame9,
  16. Aaron J. Schetter9,
  17. Hirokazu Okayama9,
  18. Curtis C. Harris9,
  19. Young Hak Kim8,
  20. Michiaki Mishima8,
  21. Jun Yokota1,10,
  22. Teruhiko Yoshida2, and
  23. Takashi Kohno1
  1. Authors' Affiliations: Divisions of 1Genome Biology, 2Genetics, and 3Refractory Cancer Research, National Cancer Center Research Institute, Divisions of 4Pathology and Clinical Laboratories, 5Thoracic Surgery, and 6Thoracic Oncology, National Cancer Center Hospital, Chuo-ku; 7Department of Metabolic Disorder, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo; 8Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan; 9Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and 10The Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Barcelona, Spain
  1. Corresponding Author:
    Takashi Kohno, Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Phone: 81-3-3542-2511; Fax: 81-3-3542-0807; E-mail: tkkohno{at}ncc.go.jp
View Full Text
PreviousNext
Back to top
Clinical Cancer Research: 20 (12)
June 2014
Volume 20, Issue 12
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
Takashi Nakaoku, Koji Tsuta, Hitoshi Ichikawa, Kouya Shiraishi, Hiromi Sakamoto, Masato Enari, Koh Furuta, Yoko Shimada, Hideaki Ogiwara, Shun-ichi Watanabe, Hiroshi Nokihara, Kazuki Yasuda, Masaki Hiramoto, Takao Nammo, Teruhide Ishigame, Aaron J. Schetter, Hirokazu Okayama, Curtis C. Harris, Young Hak Kim, Michiaki Mishima, Jun Yokota, Teruhiko Yoshida and Takashi Kohno
Clin Cancer Res June 15 2014 (20) (12) 3087-3093; DOI: 10.1158/1078-0432.CCR-14-0107

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
Takashi Nakaoku, Koji Tsuta, Hitoshi Ichikawa, Kouya Shiraishi, Hiromi Sakamoto, Masato Enari, Koh Furuta, Yoko Shimada, Hideaki Ogiwara, Shun-ichi Watanabe, Hiroshi Nokihara, Kazuki Yasuda, Masaki Hiramoto, Takao Nammo, Teruhide Ishigame, Aaron J. Schetter, Hirokazu Okayama, Curtis C. Harris, Young Hak Kim, Michiaki Mishima, Jun Yokota, Teruhiko Yoshida and Takashi Kohno
Clin Cancer Res June 15 2014 (20) (12) 3087-3093; DOI: 10.1158/1078-0432.CCR-14-0107
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results and Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Contact Guidance Controls T-cell Migration in PDAC
  • MET in Papillary RCC
  • Identification of T-cell Antigens by Minigene Screening
Show more Human Cancer Biology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement